N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide

C17H14N4OS — CID 46880420

IUPACN-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide
SMILESO=C(Nc1ccc(-c2ccncc2)c(-c2nccs2)n1)C1CC1
InChIInChI=1S/C17H14N4OS/c22-16(12-1-2-12)21-14-4-3-13(11-5-7-18-8-6-11)15(20-14)17-19-9-10-23-17/h3-10,12H,1-2H2,(H,20,21,22)
InChIKeyFJWNSNLNBIUZDY-UHFFFAOYSA-N
MW322.39 g/mol
LogP3.62
Rot. Bonds4

About N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide

N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide (PubChem CID 46880420) has the molecular formula C17H14N4OS and a molecular weight of 322.39 g/mol. Its IUPAC name is N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide.

Molecular Properties

Compound NameN-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide
PubChem CID46880420
Molecular FormulaC17H14N4OS
Molecular Weight322.39 g/mol
Exact Mass322.09
IUPAC NameN-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide
SMILESO=C(Nc1ccc(-c2ccncc2)c(-c2nccs2)n1)C1CC1
InChIInChI=1S/C17H14N4OS/c22-16(12-1-2-12)21-14-4-3-13(11-5-7-18-8-6-11)15(20-14)17-19-9-10-23-17/h3-10,12H,1-2H2,(H,20,21,22)
InChIKeyFJWNSNLNBIUZDY-UHFFFAOYSA-N
XLogP3.62
TPSA67.77 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500322.39
LogP ≤ 53.62
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Acetamide, N-[4-[2-(2-pyridinylamino)-4-thiazolyl]phenyl]-
CID 973066
(3-Methyl-pyridin-2-yl)-(4-pyridin-2-yl-thiazol-2-yl)-amine
CID 972880
N-(4-Pyridin-2-yl-thiazol-2-yl)-benzamide
CID 4119262
N-(1,3-Thiazol-2-yl)pyridin-2-amine 13
CID 5329326
3-[2-(Pyridin-4-yl)-1,3-thiazol-4-yl]-1,2,3,4-tetrahydroquinazolin-2-one
CID 11722798
3-[2-(2-Ethylpyridin-4-yl)-1,3-thiazol-4-yl]-1,2,3,4-tetrahydroquinazolin-2-one
CID 21928512
(E)-3-phenyl-N-(4-pyridin-4-yl-1,3-thiazol-2-yl)prop-2-enamide
CID 5829079
N-(4-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine
CID 704452
N-(4-(pyridin-4-yl)thiazol-2-yl)pyridin-2-amine
CID 704533
N-(4-(pyridin-3-yl)thiazol-2-yl)pyridin-2-amine
CID 704624
2-(2-cyclopropanesulfonamido-1,3-thiazol-4-yl)-2-methyl-N-{5-[6-(trifluoromethyl)pyrazin-2-yl]pyridin-2-yl}propanamide
CID 138674003
2-(4-fluorophenyl)-N-(4-pyridin-2-yl-1,3-thiazol-2-yl)acetamide
CID 2660463

Frequently Asked Questions

What is the IUPAC name of N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide?
The IUPAC name of N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide (CID 46880420) is N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide.
What is the SMILES notation for N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide?
The canonical SMILES for N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide is O=C(Nc1ccc(-c2ccncc2)c(-c2nccs2)n1)C1CC1.
What is the InChIKey of N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide?
The InChIKey is FJWNSNLNBIUZDY-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H14N4OS/c22-16(12-1-2-12)21-14-4-3-13(11-5-7-18-8-6-11)15(20-14)17-19-9-10-23-17/h3-10,12H,1-2H2,(H,20,21,22).
What are the key properties of N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide?
N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide has a molecular weight of 322.39 g/mol, XLogP of 3.62, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-pyridin-4-yl-6-(1,3-thiazol-2-yl)-2-pyridinyl]cyclopropanecarboxamide is sourced from PubChem (CID 46880420), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).